News
BD introduces landmark cell analyzer featuring breakthrough spectral and real-time cell imaging technologies: Franklin Lakes, ...
Shardul Nautiyal, Mumbai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...
BDCDA cautions on unauthorized channels and infiltration of counterfeit medicines into Karnataka: Nandita Vijayasimha, ...
91.6% of people treated with the Perjeta-based regimen were alive at ten years versus 89.8% of those treated with Herceptin, chemotherapy, and placebo (hazard ratio [HR]=0.83, 95% CI: 0.69-1.00, ...
Peethaambaran Kunnathoor, Chennai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs: Gireesh Babu, New Delhi Wednesday, May 14, 2025, 08:00 Hrs [IST] The Drugs Technical Advisor ...
Lifesciences sector maximises adoption of advanced technologies to unlock new possibilities: Nandita Vijayasimha, Bengaluru Wednesday, May 14, 2025, 08:00 Hrs [IST] Life sciences ...
Rein Therapeutics initiates RENEW phase 2 trial of LTI-03 in patients with idiopathic pulmonary fibrosis: Austin, Texas Tuesday, May 13, 2025, 18:00 Hrs [IST] Rein Therapeutics (R ...
Telangana DCA conducts special raids in pharmacies to verify QR codes on 300 formulation brands: Our Bureau, Chennai Tuesday, May 13, 2025, 13:30 Hrs [IST] The Drugs Control Admin ...
Lupin launches tolvaptan tablets in the US with 180-day exclusivity: Our Bureau, Mumbai Tuesday, May 13, 2025, 13:45 Hrs [IST] Following the recent approval received from the Unit ...
Genezen partners with Elly’s Team on development for AAV serotype 9 gene replacement therapy for NEDAMSS: Lexington, Massachusetts Tuesday, May 13, 2025, 17:00 Hrs [IST] Genezen ...
Synthego Introduces GMP SpCas9 to accelerate gene editing for therapeutic advancement: Redwood City, California Tuesday, May 13, 2025, 14:00 Hrs [IST] Synthego, a leader in biotec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results